Form 4 Filing for Liu Da David - Edesa Biotech, Inc.

On May 27, 2026, Liu Da David, a director at Edesa Biotech, Inc., acquired 19,000 Common Shares through a grant of restricted share units. This grant, issued under the Issuer's 2019 Equity Incentive Compensation Plan, will vest equally over twelve months, commencing on the grant date. The shares were acquired at a price of $0.0 per share, with the transaction being marked as direct ownership. Following this transaction, Liu Da David now holds 24,501 shares. The filing, document type 4, was signed on May 29, 2026.